Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines

被引:28
作者
Bukreyev, A
Whitehead, SS
Prussin, C
Murphy, BR
Collins, PL
机构
[1] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Lab Allerg Dis, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JVI.74.15.7151-7157.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We constructed rRSV/mIL-2, a recombinant respiratory syncytial virus (rRSV) containing the coding sequence of murine interleukin-2 (mIL-2) in a transcription cassette inserted into the G-F intergenic region, The recovered virus (rRSV/mIL-2) expressed high levels (up to 2.8 mu g/ml) of mIL-2 in cell culture. Replication of rRSV/mIL-2 in vitro was reduced up to 13.6-fold from that of wild-type (wt) rRSV, an effect that was due to the presence of the foreign insert but was not specific to mIL-2, Replication of the rRSV/mIL-2 virus in the upper and lower respiratory tracts of BALB/c mice was reduced up to 6.3-fold, an effect that was specific to mIL-2, The antibody response, including the levels of RSV-specific serum immunoglobulin G1 (IgG1), IgG2a, IgA, and total IgG, and the level of protective efficacy against wt RSV challenge were not significantly different from those of wt rRSV, Analysis of total pulmonary cytokine mRNA isolated 1 and 4 days following infection with rRSV/mIL-2 revealed elevated levels of mRNA for IL-2, gamma interferon (IFN-gamma), IL-4, IL-5, IL-6, IL-10, IL-13, and IL-12 p40 compared to those for,vt rRSV. Flow cytometry of total pulmonary mononuclear cells isolated 10 days following infection with rRSV/mIL-2 revealed increased levels of CD4(+) T lymphocytes expressing either IFN-gamma or IL-4 compared to those of wt rRSV. These elevations in cytokine mRNA or cytokine-expressing CD4(+) cells relative to those of wt rRSV-primed animals were not observed following challenge with wt RSV on day 28, Thus, the expression of mIL-2 by rRSV was associated with a modest attenuation of virus growth in vivo, induction of serum antibodies at levels comparable to that of wt rRSV, and transient increases in both the Th1 and Th2 CD4(+) lymphocytes and cytokine mRNAs compared to those of wt rRSV.
引用
收藏
页码:7151 / 7157
页数:7
相关论文
共 26 条
[1]   Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene [J].
Bukreyev, A ;
Camargo, E ;
Collins, PL .
JOURNAL OF VIROLOGY, 1996, 70 (10) :6634-6641
[2]   Interferon γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity [J].
Bukreyev, A ;
Whitehead, SS ;
Bukreyeva, N ;
Murphy, BR ;
Collins, PL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2367-2372
[3]   Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics [J].
Collins, PL ;
Whitehead, SS ;
Bukreyev, A ;
Fearns, R ;
Teng, MN ;
Juhasz, K ;
Chanock, RM ;
Murphy, BR .
ADVANCES IN VIRUS RESEARCH, VOL 54, 1999, 54 :423-451
[4]   PRODUCTION OF INFECTIOUS HUMAN RESPIRATORY SYNCYTIAL VIRUS FROM CLONED CDNA CONFIRMS AN ESSENTIAL ROLE FOR THE TRANSCRIPTION ELONGATION-FACTOR FROM THE 5'-PROXIMAL OPEN READING FRAME OF THE M2 MESSENGER-RNA IN GENE-EXPRESSION AND PROVIDES A CAPABILITY FOR VACCINE DEVELOPMENT [J].
COLLINS, PL ;
HILL, MG ;
CAMARGO, E ;
GROSFELD, H ;
CHANOCK, RM ;
MURPHY, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11563-11567
[5]  
COLLINS PL, 1996, FIELDS VIROLOGY, V2, P1313
[6]   A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV [J].
CROWE, JE ;
COLLINS, PL ;
LONDON, WT ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1993, 11 (14) :1395-1404
[7]  
CROWE JE, 1997, NEW GENERATION VACCI, P711
[8]   ATTENUATION AND IMMUNOGENICITY IN PRIMATES OF VACCINIA VIRUS RECOMBINANTS EXPRESSING HUMAN INTERLEUKIN-2 [J].
FLEXNER, C ;
MOSS, B ;
LONDON, WT ;
MURPHY, BR .
VACCINE, 1990, 8 (01) :17-21
[9]   PREVENTION OF VACCINIA VIRUS-INFECTION IN IMMUNODEFICIENT MICE BY VECTOR-DIRECTED IL-2 EXPRESSION [J].
FLEXNER, C ;
HUGIN, A ;
MOSS, B .
NATURE, 1987, 330 (6145) :259-262
[10]  
GAFFEN SL, 1998, INTERLEUKIN 2 INTERL